News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
636,281 Results
Type
Article (55627)
Company Profile (86)
Press Release (580568)
Section
Business (177858)
Career Advice (2685)
Deals (33291)
Drug Delivery (83)
Drug Development (77078)
Employer Resources (153)
FDA (15171)
Job Trends (14068)
News (311302)
Policy (30123)
Tag
Academia (2676)
Africa (876)
Alliances (45157)
Alzheimer's disease (1089)
Approvals (15104)
Arizona (120)
Artificial intelligence (69)
Asia (41563)
Australia (7050)
Bankruptcy (286)
Best Places to Work (10625)
Biosimilars (61)
Biotechnology (60)
C2C Services and Suppliers (68593)
California (1601)
Canada (847)
Cancer (478)
Career advice (2267)
Cell therapy (129)
China (136)
Clinical research (60384)
Collaboration (135)
Colorado (71)
Connecticut (68)
COVID-19 (2467)
Cystic fibrosis (72)
Data (299)
Diabetes (74)
Diagnostics (5816)
Drug pricing (69)
Earnings (59969)
Employer resources (133)
Europe (86716)
Events (92836)
Executive appointments (154)
FDA (15395)
Florida (244)
Funding (133)
Gene therapy (85)
Georgia (58)
GLP-1 (494)
Government (4441)
Healthcare (18178)
Hotbed/Location (418454)
Illinois (264)
Indiana (149)
Infectious disease (2490)
Inflammatory bowel disease (90)
Interviews (515)
IPO (14753)
Job creations (3542)
Job search strategy (1920)
Kansas (89)
Layoffs (427)
Legal (6810)
Lung cancer (105)
Manufacturing (82)
Maryland (356)
Massachusetts (1214)
Medical device (12368)
Medtech (12372)
Mergers & acquisitions (18454)
Metabolic disorders (225)
Michigan (123)
Minnesota (184)
Neuroscience (1226)
New Jersey (534)
New York (518)
NextGen Class of 2024 (6381)
Non-profit (4410)
North Carolina (582)
Northern California (736)
Obesity (136)
Ohio (98)
Opinion (203)
Patents (64)
Pennsylvania (498)
People (57595)
Phase I (18870)
Phase II (26634)
Phase III (19589)
Pipeline (103)
Policy (60)
Postmarket research (2433)
Preclinical (7943)
Press Release (65)
Rare diseases (130)
Real estate (6092)
Recruiting (62)
Regulatory (19796)
Research institute (2463)
Resumes & cover letters (402)
South America (1191)
Southern California (676)
Startups (3395)
Texas (218)
United States (7548)
Vaccines (460)
Washington State (220)
Weight loss (118)
Date
Today (168)
Last 7 days (684)
Last 30 days (2218)
Last 365 days (34294)
2024 (23945)
2023 (36909)
2022 (47536)
2021 (52380)
2020 (51341)
2019 (45253)
2018 (34546)
2017 (31194)
2016 (30504)
2015 (36009)
2014 (29053)
2013 (25384)
2012 (26671)
2011 (26929)
2010 (25379)
636,281 Results for "serum institute of india ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types
ImmunityBio, Inc., has signed an exclusive global arrangement with the Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses produced, to supply ImmunityBio with Bacillus Calmette-Guerin.
May 2, 2024
·
12 min read
Business
ValGenesis and Autocal Announce Strategic Alliance to Strengthen Quality and Compliance for Life Sciences in India
ValGenesis Inc. and Autocal Solutions Pvt. Ltd. have entered into a strategic partnership to address quality assurance and compliance challenges in the life sciences industry in India.
May 29, 2024
·
3 min read
Policy
EU Says India’s Alchem Is Part of International Drug Price-Fixing Cartel
The European Commission has tagged India-based pharma Alchem as being part of a global cartel that coordinates the pricing of a pharmaceutical ingredient in the antispasmodic drug Buscopan.
June 14, 2024
·
2 min read
·
Tristan Manalac
BioMidwest
Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India
Cardio Diagnostics Holdings, Inc, a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, announced a significant move to transform global cardiovascular health, by entering into a Supply and Distribution Agreement with one of India’s premier organizations, Aimil Ltd.
October 17, 2023
·
5 min read
Fourth BRIIT Conference in India Features IceCure’s ProSense® in Breast Cancer Imaging & Interventions Workshop
IceCure Medical Ltd. announced ProSense® was featured in a number of sessions, including one titled “Minimal access imaging guided therapies: cryoablative therapies in breast pathologies,” at the fourth Breast Imaging & Interventional Techniques conference at Tata Memorial Centre in Mumbai, India on February 24, 2024.
February 27, 2024
·
4 min read
Genetown
Serum Detect Launches with Novel T-Cell Analysis Approach for Cancer Early Detection at AACR
Serum Detect, a cancer diagnostics company, is debuting a novel and promising approach for cancer early detection at the upcoming American Association for Cancer Research (AACR) conference.
March 28, 2024
·
4 min read
Biotech Bay
GeminiBio launches human serum AB product for global cell therapy market
Gemini Bioproducts, LLC today announced the launch of a new human AB serum product for the cell therapy and regenerative medicine markets.
February 26, 2024
·
3 min read
Genetown
Serum Detect Presents Data on Novel T-Cell Analysis Approach for Cancer Early Detection at AACR
Serum Detect, Inc., a cancer diagnostics company advancing new technologies for early detection of cancer, today announced the presentation of new data at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA.
April 8, 2024
·
3 min read
Policy
IceCure’s ProSense® Deepens Regulatory Approval in India
IceCure Medical Ltd. (NASDAQ: ICCM) (“IceCure”, “IceCure Medical” or the “Company”) today announced that the Central Drugs Standard Control Organization (“CDSCO”) in India has granted approval for the ProSense® system based on the CDSCO’s updated regulatory requirements.
November 29, 2023
·
4 min read
Press Releases
Clarivate Announces 15th Annual Pharmavision India Conference Agenda
September 18, 2024
·
3 min read
1 of 63,629
Next
